In addition, the serum level of FA1 is elevated in some human pathological conditions including neurofibromatosis (Jensen et al., 1999), renal failure (10 times higher) (Jensen et al., 1997), and small cell lung cancer patients (10–1000 times higher) (Harken et al., 1999). The gene discussed is DLK1; the disease is neurofibromatosis.